Finder makes money from featured partners, but editorial opinions are our own. Advertiser disclosure

How to buy Third Harmonic Bio stock (THRD)

Learn how to buy Third Harmonic Bio stock in 5 easy steps.

Third Harmonic Bio is a biotechnology business based in the US. Third Harmonic Bio shares (THRD) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $11.35 – a decrease of 4.06% over the previous week. Third Harmonic Bio employs 51 staff and has a market cap (total outstanding shares value) of 0.00.

Our top picks for where to buy Third Harmonic Bio stock

Top pick for advanced traders

Go to site
  • Trade options, futures, options on futures, stocks, ETFs
  • $0 commission to close options
  • Pro-grade platform and risk analysis tools

Our pick for investing by theme

Go to site
  • Trade $0 commission stocks & ETFs with as little as $1
  • Earn up to $300 with qualifying deposits
  • Discover new opportunities with Opto's AI-driven thematic investing system
  • Theme and ETF screener

Our pick for stock bonuses

Go to site
  • Trade stocks, options, ETFs, mutual funds, alternative asset funds
  • $0 commission on stocks, ETFs and options with no options contract fees
  • Get up to $1,000 in stock when you fund a new account within 30 days
  • Complimentary access to a financial planner
Probability of member receiving $1,000 is 0.028%

How to buy Third Harmonic Bio stock

  1. Choose a stock trading platform. Use our comparison table
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – THRD. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Buy Third Harmonic Bio stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 4 of 4
Name Product USFST Ratings Available asset types Stock trade fee Minimum deposit Cash sweep APY Signup bonus
Tastytrade
Finder Score: 4.4 / 5: ★★★★★
Tastytrade
★★★★★
Stocks, Options, ETFs, Cryptocurrency, Futures, Treasury Bills
$0
$0
N/A
Get $50-$5,000
Competitive, capped options commissions, with a reliable trading platform designed for serious traders.
OPTO
Finder Score: 3.8 / 5: ★★★★★
OPTO
★★★★★
Stocks, ETFs
$0
$0
N/A
Earn up to $300
AI-driven thematic investing, with proprietary research, fractional shares and commission-free stocks and ETFs.
SoFi Invest®
Finder Score: 4.3 / 5: ★★★★★
SoFi Invest®
★★★★★
Stocks, Options, Mutual funds, ETFs, Alternatives
$0
$0
0.02%
Get up to $1,000 in stock
Zero-commission stocks, ETFs and options, with no options per-contract fees. Plus, a complimentary access to financial planners.
Public.com
Finder Score: 4.4 / 5: ★★★★★
Public.com
★★★★★
Stocks, Bonds, Options, ETFs, Cryptocurrency, Alternatives, Treasury Bills, High-yield cash account
$0
$0
4.35%
Get up to $10,000 and transfer fees covered
Build a diversified portfolio of stocks, bonds, options, ETFs, crypto and alternative assets, with a high-yield cash account and options contract rebates.
loading

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Third Harmonic Bio stock price (NASDAQ: THRD)

Use our graph to track the performance of THRD stocks over time.

Third Harmonic Bio shares at a glance

Information last updated 2024-12-12.
Latest market close$11.35
52-week range$8.08 - $16.94
50-day moving average $12.90
200-day moving average $12.19
Wall St. target price$19.00
PE ratio N/A
Dividend yield N/A
Earnings per share (TTM) $-0.97

Is it a good time to buy Third Harmonic Bio stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Third Harmonic Bio price performance over time

Historical closes compared with the close of $11.12 from 2024-12-16

1 week (2024-12-10) -11.68%
1 month (2024-11-18) -3.30%
3 months (2024-09-17) -12.78%
6 months (2024-06-17) -14.13%
1 year (2023-12-15) 1.18%
2 years (2022-12-16) 152.73%
3 years (2021-12-14) N/A
5 years (2019-12-14) N/A

Third Harmonic Bio financials

Gross profit TTM $0
Return on assets TTM -11.26%
Return on equity TTM -13.81%
Profit margin 0%
Book value $6.59
Market Capitalization $533 million

TTM: trailing 12 months

Third Harmonic Bio share dividends

We're not expecting Third Harmonic Bio to pay a dividend over the next 12 months.

Third Harmonic Bio share price volatility

Over the last 12 months, Third Harmonic Bio's shares have ranged in value from as little as $8.075 up to $16.94. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Third Harmonic Bio's is 2.861. This would suggest that Third Harmonic Bio's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Third Harmonic Bio overview

Third Harmonic Bio, Inc. , a biopharmaceutical company, focuses on the development of the medicine for the treatment of dermal, respiratory, and gastrointestinal inflammatory diseases. The company develops oral small-molecule inhibitors of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. It is also developing THB335, an oral small molecule KIT inhibitor for the treatment of mast cell-mediated skin, respiratory, and gastrointestinal conditions. The company was formerly known as Project IGE, Inc. and changed its name to Third Harmonic Bio, Inc. in June 2019.

Frequently asked questions

What percentage of Third Harmonic Bio is owned by insiders or institutions?
Currently 9.046% of Third Harmonic Bio shares are held by insiders and 92.401% by institutions.
How many people work for Third Harmonic Bio?
Latest data suggests 51 work at Third Harmonic Bio.
When does the fiscal year end for Third Harmonic Bio?
Third Harmonic Bio's fiscal year ends in December.
Where is Third Harmonic Bio based?
Third Harmonic Bio's address is: 1700 Montgomery Street, San Francisco, CA, United States, 94111
What is Third Harmonic Bio's ISIN number?
Third Harmonic Bio's international securities identification number is: US88427A1079

More guides on Finder

Ask a question

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site